To explore the efficacy and mechanism of sodium-glucose cotransporter (SGLT)-2 inhibitor dapagliflozin in the treatment of patients with heart failure with preserved ejection fraction (HFpEF).
HFpEF patients admitted to Fugou Huimin Hospital of Traditional Chinese Medicine from January 2023 to December 2024 were selected as the subjects and divided into the observation group and the control group, with 50 cases in each group.The control group was treated with conventional therapy, while the observation group was treated with dapagliflozin in combination. The changes of echocardiographic indicators, inflammatory factors, cardiac function indicators and myocardial fibrosis indicators in the two groups were compared, and the incidences of adverse reactions and major cardiovascular event (MACE) were also compared.
After treatment, the left ventricular end-diastolic diameter, left ventricular end-systolic diameter, peak velocity of early mitral valve blood flow/peak velocity of early mitral valve annulus in the observation group were all lower than those in the control group, and the left ventricular ejection fraction was higher, with significant differences (P<0.05). The levels of high-sensitivity C-reactive protein, interleukin-6, N-terminal pro-brain natriuretic peptide, creatine kinase, creatine kinase isoenzyme, α -hydroxybutyrate dehydrogenase, soluble growth-stimulating expression gene 2 protein, connective tissue growth factor, and matrix metalloproteinase-9 in the observation group were all lower than those in the control group, and the differences were all significant (P<0.05).After a 3-month follow-up, the incidence of MACE in the observation group was lower than that in the control group (P<0.05).
Dapagliflozin has a significant short-term therapeutic effect on patients with HFpEF, which can reduce the inflammatory response of the body, improve cardiac function and myocardial fibrosis, and lower the incidence of short-term MACE. Moreover, it has good safety.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |